Associate Professor Philip Robinson

Taylor, William J., Van der Linden, Sjef, Robinson, Philip C., Brown, Matthew, Østergaard, Mikkel and Gensler, Lianne S. (2024). Axial Spondyloarthritis. Firestein & Kelley's Textbook of Rheumatology, 2-Volume Set. (pp. 1309-1336.e10) Elsevier. doi: 10.1016/B978-0-323-93540-1.00076-2

van der Linden, Sjef, Brown, Matthew, Kenna, Tony, Maksymowych, Walter and Robinson, Philip (2016). Ankylosing Spondylitis. Kelley and Firestein's Textbook of Rheumatology. (pp. 1256-1279.e5) Philadelphia, PA United States: Elsevier. doi: 10.1016/B978-0-323-31696-5.00075-9

Hoon, Elizabeth, Edwards, Jessie, Robinson, Philip, Rowett, Debra, Stocks, Nigel, Keen, Helen I. and Hill, Catherine L. (2024). How is gout currently managed, and is there interest in changing the way we deliver care? A qualitative exploratory study. Australian Journal of General Practice, 53 (11), 864-871. doi: 10.31128/AJGP-09-23-6980

Major, Tanya J., Takei, Riku, Matsuo, Hirotaka, Leask, Megan P., Sumpter, Nicholas A., Topless, Ruth K., Shirai, Yuya, Wang, Wei, Cadzow, Murray J., Phipps-Green, Amanda J., Li, Zhiqiang, Ji, Aichang, Merriman, Marilyn E., Morice, Emily, Kelley, Eric E., Wei, Wen-Hua, McCormick, Sally P. A., Bixley, Matthew J., Reynolds, Richard J., Saag, Kenneth G., Fadason, Tayaza, Golovina, Evgenia, O’Sullivan, Justin M., Stamp, Lisa K., Dalbeth, Nicola, Abhishek, Abhishek, Doherty, Michael, Roddy, Edward, Jacobsson, Lennart T. H. ... Merriman, Tony R. (2024). A genome-wide association analysis reveals new pathogenic pathways in gout*. Nature Genetics, 56 (11), 2392-2406. doi: 10.1038/s41588-024-01921-5

Brooks, Jonathon, Montgomery, Anna, Dalbeth, Nicola, Sapsford, Mark, Ngan Kee, Rachel, Cooper, Amy, Quincey, Vicki, Bhana, Suleman, Gore-Massy, Monique, Hausmann, Jonathan, Liew, Jean, Machado, Pedro M., Sufka, Paul, Sirotich, Emily, Robinson, Philip, Wallace, Zachary, Yazdany, Jinoos and Grainger, Rebecca (2023). Omicron variant infection in inflammatory rheumatological conditions – outcomes from a COVID-19 naive population in Aotearoa New Zealand. The Lancet Regional Health - Western Pacific, 38 100843, 1-11. doi: 10.1016/j.lanwpc.2023.100843

Wang, Harry, Dewidar, Omar, Whittle, Samuel L., Ghogomu, Elizabeth, Hazlewood, Glen, Leder, Karin, Mbuagbaw, Lawrence, Pardo Pardo, Jordi, Robinson, Philip C., Buchbinder, Rachelle and Welch, Vivian (2023). Equity considerations in COVID‐19 vaccination studies of individuals with autoimmune inflammatory rheumatic diseases. Arthritis Care and Research, 75 (5), 967-974. doi: 10.1002/acr.25034

Sim, Bernice L., Sim, Beatrice Z., Tunbridge, Matthew, Liew, David F. L. and Robinson, Philip C. (2023). Examining the characteristics of colchicine-induced myelosuppression in clinical cases: a systematic review. The Journal of Rheumatology, 50 (3), 400-407. doi: 10.3899/jrheum.220524

Machado, Pedro M, Schäfer, Martin, Mahil, Satveer K, Liew, Jean, Gossec, Laure, Dand, Nick, Pfeil, Alexander, Strangfeld, Anja, Regierer, Anne Constanze, Fautrel, Bruno, Alonso, Carla Gimena, Saad, Carla G S, Griffiths, Christopher E M, Lomater, Claudia, Miceli-Richard, Corinne, Wendling, Daniel, Alpizar Rodriguez, Deshire, Wiek, Dieter, Mateus, Elsa F, Sirotich, Emily, Soriano, Enrique R, Ribeiro, Francinne Machado, Omura, Felipe, Rajão Martins, Frederico, Santos, Helena, Dau, Jonathan, Barker, Jonathan N, Hausmann, Jonathan, Hyrich, Kimme L ... Smith, Catherine H (2023). Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Annals of the Rheumatic Diseases, 82 (5), 698-709. doi: 10.1136/ard-2022-223499

McEwan, Tim, Bhambra, Jaspreet, Liew, David F. and Robinson, Philip C (2023). Systematic review of colchicine neuromyopathy: risk factors, duration and resolution. Seminars in Arthritis and Rheumatism, 58 152150, 152150. doi: 10.1016/j.semarthrit.2022.152150

Conway, Richard, Nikiphorou, Elena, Demetriou, Christiana A., Low, Candice, Leamy, Kelly, Ryan, John G., Kavanagh, Ronan, Fraser, Alexander D., Carey, John J., O’Connell, Paul, Flood, Rachael M., Mullan, Ronan H., Kane, David J., Stafford, Frances, Robinson, Philip C., Liew, Jean W., Grainger, Rebecca, McCarthy, Geraldine M. and On behalf of the COVID-19 Global Rheumatology Alliance (2023). Outcomes of COVID-19 in people with rheumatic and musculoskeletal disease in Ireland over the first 2 years of the pandemic. Irish Journal of Medical Science, 192 (5), 1-6. doi: 10.1007/s11845-022-03265-7

Yang, Victor, Kragstrup, Tue W., McMaster, Christopher, Reid, Pankti, Singh, Namrata, Haysen, Stine R., Robinson, Philip C. and Liew, David F. L. (2023). Managing cardiovascular and cancer risk associated with JAK inhibitors. Drug Safety, 46 (11), 1049-1071. doi: 10.1007/s40264-023-01333-0

Tsakas, James J., Liew, David F. L., Adams, Cameron L., Hill, Catherine L., Proudman, Susanna, Whittle, Samuel, Buchbinder, Rachelle and Robinson, Philip C. (2022). Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees. BMC Rheumatology, 6 (1) 59, 59. doi: 10.1186/s41927-022-00290-y

Jatuworapruk, Kanon, Satpanich, Panchalee, Robinson, Philip C. and Grainger, Rebecca (2022). Prevalence, risk factors, and outcomes of gout flare in patients hospitalized for PCR-confirmed COVID-19: a multicenter retrospective cohort study. The Journal of Rheumatology, 50 (4), 556-563. doi: 10.3899/jrheum.220762

Jatuworapruk, Kanon, Montgomery, Anna, Gianfrancesco, Milena, Conway, Richard, Durcan, Laura, Graef, Elizabeth R., Jayatilleke, Aruni, Keen, Helen, Kilian, Adam, Young, Kristen, Carmona, Loreto, Cogo, Adriana Karina, Duarte‐García, Alí, Gossec, Laure, Hasseli, Rebecca, Hyrich, Kimme L., Langlois, Vincent, Lawson‐Tovey, Saskia, Malcata, Armando, Mateus, Elsa F, Schafer, Martin, Scirè, Carlo Alberto, Sigurdardottir, Valgerdur, Sparks, Jeffrey A., Strangfeld, Anja, Xavier, Ricardo M., Bhana, Suleman, Gore‐Massy, Monique, Hausmann, Jonathan ... Robinson, Philip C. (2022). Characteristics and outcomes of people with gout hospitalized due to COVID ‐19: data from the COVID ‐19 Global Rheumatology Alliance Physician‐Reported Registry. ACR Open Rheumatology, 4 (11), 948-953. doi: 10.1002/acr2.11495

Ugarte‐Gil, Manuel F., Alarcón, Graciela S., Seet, Andrea M., Izadi, Zara, Montgomery, Anna D., Duarte‐García, Alí, Gilbert, Emily L., Valenzuela‐Almada, Maria O., Wise, Leanna, Sparks, Jeffrey A., Hsu, Tiffany Y.‐T., D'Silva, Kristin M., Patel, Naomi J., Sirotich, Emily, Liew, Jean W., Hausmann, Jonathan S., Sufka, Paul, Grainger, Rebecca, Bhana, Suleman, Wallace, Zachary, Jacobsohn, Lindsay, Strangfeld, Anja, Mateus, Elsa F., Hyrich, Kimme L., Gossec, Laure, Carmona, Loreto, Lawson‐Tovey, Saskia, Kearsley‐Fleet, Lianne, Schaefer, Martin ... Yazdany, Jinoos (2022). Association between race/ethnicity and COVID ‐19 outcomes in systemic lupus erythematosus patients from the United States: data from the COVID ‐19 Global Rheumatology Alliance. Arthritis Care and Research, 75 (1), 53-60. doi: 10.1002/acr.25039

Izadi, Zara, Gianfrancesco, Milena A., Aguirre, Alfredo, Strangfeld, Anja, Mateus, Elsa F., Hyrich, Kimme L., Gossec, Laure, Carmona, Loreto, Lawson‐Tovey, Saskia, Kearsley‐Fleet, Lianne, Schaefer, Martin, Seet, Andrea M., Schmajuk, Gabriela, Jacobsohn, Lindsay, Katz, Patricia, Rush, Stephanie, Al‐Emadi, Samar, Sparks, Jeffrey A., Hsu, Tiffany Y‐T, Patel, Naomi J., Wise, Leanna, Gilbert, Emily, Duarte‐García, Alí, Valenzuela‐Almada, Maria O., Ugarte‐Gil, Manuel F., Ribeiro, Sandra Lúcia Euzébio, de Oliveira Marinho, Adriana, de Azevedo Valadares, Lilian David, Giuseppe, Daniela Di ... Global Rheumatology Alliance Registry (2022). Development of a prediction model for COVID‐19 acute respiratory distress syndrome in patients with rheumatic diseases: results from the Global Rheumatology Alliance Registry. ACR Open Rheumatology, 4 (10), 872-882. doi: 10.1002/acr2.11481

van der Horst-Bruinsma, Irene E., Robinson, Philip C., Favalli, Ennio G., Verbraak, Frank D., Kim, Mindy, Kumke, Thomas, Bauer, Lars, Hoepken, Bengt and Deodhar, Atul (2022). Certolizumab pegol treatment in patients with axial-spondyloarthritis-associated acute anterior uveitis: a narrative review. Rheumatology and Therapy, 9 (6), 1481-1497. doi: 10.1007/s40744-022-00486-1

Maguire, Sinead, Al-Emadi, Samar, Alba, Paula, Aguiar, Mathia Cecilia, Al Lawati, Talal, Alle, Gelsomina, Bermas, Bonnie, Bhana, Suleman, Branimir, Anic, Bulina, Inita, Clowse, Megan, Cogo, Karina, Colunga, Iris, Cook, Claire, Cortez, Karen J., Dao, Kathryn, Gianfrancesco, Milena, Gore-Massey, Monique, Gossec, Laure, Grainger, Rebecca, Hausman, Jonathon, Hsu, Tiffany Y. T., Hyrich, Kimme, Isnardi, Carolina, Kawano, Yumeko, Kilding, Rachael, Kusevich, Daria A., Lawson-Tovey, Saskia, Liew, Jean ... Conway, Richard (2022). Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status. Rheumatology, 62 (4), 1621-1626. doi: 10.1093/rheumatology/keac534

McMaster, Christopher, Liew, David F. L., Lester, Susan, Rischin, Adam, Black, Rachel J., Chand, Vibhasha, Fletcher, Ashley, Lassere, Marissa N., March, Lyn, Robinson, Philip C., Buchbinder, Rachelle and Hill, Catherine L. (2022). COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort. Rheumatology, 62 (4), 1460-1466. doi: 10.1093/rheumatology/keac503

Yeoh, Su-Ann, Gianfrancesco, Milena, Lawson-Tovey, Saskia, Hyrich, Kimme L., Strangfeld, Anja, Gossec, Laure, Carmona, Loreto, Mateus, Elsa F., Schäfer, Martin, Richez, Christophe, Hachulla, Eric, Holmqvist, Marie, Scirè, Carlo Alberto, Lorenz, Hanns-Martin, Voll, Reinhard E., Hasseli, Rebecca, Jayatilleke, Arundathi, Hsu, Tiffany Y.-T., D’Silva, Kristin M., Pimentel-Quiroz, Victor R., Vasquez del Mercado, Monica, Shinjo, Samuel Katsuyuki, Neto, Edgard Torres dos Reis, Junior, Laurindo Ferreira da Rocha, de Oliveira e Silva Montandon, Ana Carolina, Pons-Estel, Guillermo J., Ornella, Sofía, D'Angelo Exeni, Maria Eugenia, Velozo, Edson ... Machado, Pedro M. (2022). Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. RMD Open, 8 (2) e002508, 1-8. doi: 10.1136/rmdopen-2022-002508

Robinson, Philip C., Machado, Pedro M., Haroon, Nigil, Gensler, Lianne S., Reveille, John D., Taieb, Vanessa, Vaux, Thomas, Fleurinck, Carmen, Oortgiesen, Marga, de Peyrecave, Natasha and Deodhar, Atul (2022). Minimal impact of the COVID‐19 pandemic on disease activity and health‐related quality of life in patients with ankylosing spondylitis receiving bimekizumab: exploratory analyses from a phase 2b open‐label extension study. ACR Open Rheumatology, 4 (9), 819-824. doi: 10.1002/acr2.11486

Topless, Ruth, Green, Ralph, Morgan, Sarah L., Robinson, Philip, Merriman, Tony and Gaffo, Angelo L. (2022). Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case–control analysis from the UK Biobank. BMJ Open, 12 (8) e062945, 1-8. doi: 10.1136/bmjopen-2022-062945

Liew, David F. L. and Robinson, Philip C. (2022). Preventive medicine in rheumatology: COVID-19 and its lessons for better health outcomes. The Lancet Rheumatology, 4 (11), e743-e745. doi: 10.1016/s2665-9913(22)00229-6

Tam, Hoi Ki Joshua, Robinson, Philip C. and Nash, Peter (2022). Inhibiting IL-17A and IL-17F in rheumatic disease: therapeutics help to elucidate disease mechanisms. Current Rheumatology Reports, 24 (10), 310-320. doi: 10.1007/s11926-022-01084-4

Robinson, Philip C and Yazdany, Jinoos (2022). Racial and ethnic differences in COVID-19 outcomes: a call to action. The Lancet Rheumatology, 4 (7), e455-e457. doi: 10.1016/S2665-9913(22)00135-7

Robinson, Philip C., Maksymowych, Walter P., Gensler, Lianne S., Hall, Stephen, Rudwaleit, Martin, Hoepken, Bengt, Bauer, Lars, Kumke, Thomas, Kim, Mindy, de Peyrecave, Natasha and Deodhar, Atul (2022). Certolizumab pegol efficacy in patients with non‐radiographic axial spondyloarthritis stratified by baseline MRI and C‐reactive protein status: an analysis from the C‐axSpAnd study. ACR Open Rheumatology, 4 (9), 794-801. doi: 10.1002/acr2.11469

Konig, Maximilian F, Grzes, Katarzyna M, Robinson, Philip C and Pearce, Edward J (2022). Sulfasalazine: a risk factor for severe COVID-19?. The Lancet Rheumatology, 4 (6), e388-e389. doi: 10.1016/S2665-9913(22)00067-4

Conway, Richard, Nikiphorou, Elena, Demetriou, Christiana A, Low, Candice, Leamy, Kelly, Ryan, John G, Kavanagh, Ronan, Fraser, Alexander D, Carey, John J, O’Connell, Paul, Flood, Rachael M, Mullan, Ronan H, Kane, David J, Ambrose, Nicola, Stafford, Frances, Robinson, Philip C, Liew, Jean W, Grainger, Rebecca, McCarthy, Geraldine M, Dahou, Brahim, Quintana, Rosana, Gómez, Gimena, Roberts, Karen, Baez, Roberto Miguel, Coello, Vanessa Castro, Salinas, María J. Haye, Maldonado, Federico Nicolas, Torres, Alvaro Andres Reyes, Alle, Gelsomina ... on behalf of the COVID-19 Global Rheumatology Alliance (2022). Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry. Rheumatology, 61 (SI2), SI151-SI156. doi: 10.1093/rheumatology/keac142

Chock, Eugenia Yupei, Putman, Michael, Conway, Richard, Danila, Maria I., Hoyer, Bimba, Hsieh, Evelyn, Jayatilleke, Arundathi, Kilian, Adam, Leipe, Jan, Liew, Jean W., Machado, Pedro M., Robinson, Philip C., Singh, Namrata, Ung, Natasha, Yeoh, Su-Ann, Wallace, Zachary S., Grainger, Rebecca and Cappelli, Laura C. (2022). Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey. Rheumatology Advances in Practice, 6 (2) rkac039, 1-10. doi: 10.1093/rap/rkac039

Nidorf, Stefan M., Layland, Jamie, Robinson, Philip C., Patel, Sanjay, Psaltis, Peter J. and Thompson, Peter L. (2022). Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease. Medical Journal of Australia, 216 (8), 385-387. doi: 10.5694/mja2.51488

Robinson, Philip C., Liew, David F. L., Tanner, Helen L., Grainger, John R., Dwek, Raymond A., Reisler, Ronald B., Steinman, Lawrence, Feldmann, Marc, Ho, Ling-Pei, Hussell, Tracy, Moss, Paul, Richards, Duncan and Zitzmann, Nicole (2022). COVID-19 therapeutics: challenges and directions for the future. Proceedings of the National Academy of Sciences, 119 (15) e2119893119, e2119893119. doi: 10.1073/pnas.2119893119

Putman, Michael, Kennedy, Kevin, Sirotich, Emily, Liew, Jean W, Sattui, Sebastian E, Moni, Tarin T, Akpabio, Akpabio A, Alpizar-Rodriguez, Deshire, Angevare, Saskya, Beesley, Richard P, Berenbaum, Francis, Bulina, Inita, Chock, Yu Pei Eugenia, Conway, Richard, Duarte-García, Ali, Singh, Aman Dev, Duff, Eimear, Durrant, Karen L, Gheita, Tamer A, Hill, Catherine L, Howard, Richard, Hoyer, Bimba F, Hsieh, Evelyn, el Kibbi, Lina, Kilian, Adam, Kim, Alfred H J, Liew, David F L, Lo, Chieh, Mateus, Elsa F ... Simard, Julia F (2022). COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. The Lancet Rheumatology, 4 (4), e237-e240. doi: 10.1016/S2665-9913(22)00001-7

Topless, Ruth K., Gaffo, Angelo, Stamp, Lisa K., Robinson, Philip C., Dalbeth, Nicola and Merriman, Tony R. (2022). Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study. The Lancet Rheumatology, 4 (4), e274-e281. doi: 10.1016/S2665-9913(21)00401-X

Tai, Vicky, Robinson, Philip C. and Dalbeth, Nicola (2022). Gout and the COVID-19 pandemic. Current opinion in rheumatology, 34 (2), 111-117. doi: 10.1097/BOR.0000000000000860

Grainger, Rebecca, Kim, Alfred H. J., Conway, Richard, Yazdany, Jinoos and Robinson, Philip C. (2022). COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. Nature Reviews Rheumatology, 18 (4), 191-204. doi: 10.1038/s41584-022-00755-x

Kragstrup, Tue Wenzel, Glintborg, Bente, Svensson, Annemarie L, McMaster, Christopher, Robinson, Philip C, Deleuran, Bent and Liew, David FL (2022). Waiting for JAK inhibitor safety data. RMD Open, 8 (1) e002236, e002236. doi: 10.1136/rmdopen-2022-002236

Young, Kristen, Yeoh, Su-Ann, Putman, Michael, Sattui, Sebastian, Conway, Richard, Graef, Elizabeth, Kilian, Adam, Konig, Maximilian, Sparks, Jeffrey, Ugarte-Gil, Manuel, Upton, Laura, Berenbaum, Francis, Bhana, Suleman, Costello, Wendy, Hausmann, Jonathan, Machado, Pedro, Robinson, Philip, Sirotich, Emily, Sufka, Paul, Yazdany, Jinoos, Liew, Jean, Grainger, Rebecca, Wallace, Zachary and Jayatilleke, Arundathi (2022). The impact of COVID-19 on rheumatology training: results from the COVID-19 Global Rheumatology Alliance trainee survey. Rheumatology Advances in Practice, 6 (1) rkac001, rkac001. doi: 10.1093/rap/rkac001

Ugarte-Gil, Manuel Francisco, Alarcón, Graciela S., Izadi, Zara, Duarte-García, Ali, Reátegui-Sokolova, Cristina, Clarke, Ann Elaine, Wise, Leanna, Pons-Estel, Guillermo J., Santos, Maria Jose, Bernatsky, Sasha, Ribeiro, Sandra Lúcia Euzébio, Al Emadi, Samar, Sparks, Jeffrey A., Hsu, Tiffany Y. -T., Patel, Naomi J., Gilbert, Emily L., Valenzuela-Almada, Maria O., Jönsen, Andreas, Landolfi, Gianpiero, Fredi, Micaela, Goulenok, Tiphaine, Devaux, Mathilde, Mariette, Xavier, Queyrel, Viviane, Romão, Vasco C., Sequeira, Graca, Hasseli, Rebecca, Hoyer, Bimba, Voll, Reinhard E. ... Yazdany, Jinoos (2022). Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. Annals of the Rheumatic Diseases, 81 (7) -221636, annrheumdis-2021. doi: 10.1136/annrheumdis-2021-221636

Feterman Jimenez, Dominique, Duron, Garret, Hendin, Joshua, Mantovani Cardoso, Eduardo, Valenzuela-Almada, Maria O, Vallejo, Sebastian, Duarte-Garcia, Ali, Sufka, Paul, Whittle, Samuel L, Robinson, Philip C, Prokop, Larry J and Putman, Michael S (2022). Industry involvement in rheumatology consensus-based recommendations: a systematic review. The Lancet Rheumatology, 4 (2), e145-e152. doi: 10.1016/S2665-9913(21)00332-5

Truong, Steven L., McEwan, Tim, Bird, Paul, Lim, Irwin, Saad, Nivene F., Schachna, Lionel, Taylor, Andrew L. and Robinson, Philip C. (2022). Australian consensus statements for the assessment and management of non-radiographic axial spondyloarthritis. Rheumatology and Therapy, 9 (1), 1-24. doi: 10.1007/s40744-021-00416-7

Liew, David F L and Robinson, Philip C (2022). What does endemic COVID-19 mean for the future of rituximab?. The Lancet Rheumatology, 4 (1), e3-e5. doi: 10.1016/S2665-9913(21)00362-3

Robinson, Philip C., Terkeltaub, Robert, Pillinger, Michael H., Shah, Binita, Karalis, Vangelis, Karatza, Eleni, Liew, David, Imazio, Massimo, Cornel, Jan H., Thompson, Peter L. and Nidorf, Mark (2022). Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease. The American Journal of Medicine, 135 (1), 32-38. doi: 10.1016/j.amjmed.2021.07.025

Conway, Richard, Brouwer, Elisabeth, van der Geest, Kornelis S.M., Mackie, Sarah L., Mehta, Puja, Putman, Michael, Robinson, Philip and Sattui, Sebastian (2022). Dr. Conway et al reply. The Journal of Rheumatology, 49 (1), 120.2-121. doi: 10.3899/jrheum.2100913

Niemi, Mari E. K., Karjalainen, Juha, Daly, Mark, Ganna, Andrea, Mehtonen, Juha, Cordioli, Mattia, Kaunisto, Mari, Pigazzini, Sara, Donner, Kati, Kivinen, Katja, Palotie, Aarno, Daly, Mark J., Liao, Rachel G., Kanai, Masahiro, Veerapen, Kumar, Minica, Camelia, Trankiem, Amy, Balaconis, Mary K., Nguyen, Huy, Solomonson, Matthew, Francioli, Laurent, Wang, Qingbo, Green, Robert C., Bryant, Sam, Finucane, Hilary, Martin, Alicia R., Zhou, Wei, Nkambule, Lindokuhle, Karczewski, Konrad J. ... COVID-19 Host Genetics Initiative (2021). Mapping the human genetic architecture of COVID-19. Nature, 600 (7889), 472-477+. doi: 10.1038/s41586-021-03767-x

Wallace, Zachary S, Sparks, Jeffrey A, Robinson, Philip C, Machado, Pedro M and Yazdany, Jinoos (2021). Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al. Annals of the Rheumatic Diseases, 82 (7), e158-e158. doi: 10.1136/annrheumdis-2021-220960

Robinson, Philip C., Frampton, Christopher, Phipps-Green, Amanda, Neogi, Tuhina, Stamp, Lisa, Taylor, William, Merriman, Tony R. and Dalbeth, Nicola (2021). Longitudinal development of incident gout from low-normal baseline serum urate concentrations: individual participant data analysis. BMC Rheumatology, 5 (1) 33, 33. doi: 10.1186/s41927-021-00204-4

Sattui, Sebastian E, Conway, Richard, Putman, Michael S, Seet, Andrea M, Gianfrancesco, Milena A, Beins, Kaley, Hill, Catherine, Liew, David, Mackie, Sarah L, Mehta, Puja, Neill, Lorna, Gomez, Gimena, Salinas, Maria Isabel Haye, Maldonado, Federico Nicolas, Mariz, Henrique Ataide, de Sousa Studart, Samia Araujo, Araujo, Nafice Costa, Knight, Ann, Rozza, Davide, Quartuccio, Luca, Samson, Maxime, Bally, Stéphane, Maria, Alexandre TJ, Chazerain, Pascal, Hasseli, Rebecca, Müller-Ladner, Ulf, Hoyer, Bimba F, Voll, Reinhard, Torres, Rita Pinheiro ... Quiceno, Guillermo (2021). Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study. The Lancet Rheumatology, 3 (12), e855-e864. doi: 10.1016/S2665-9913(21)00316-7

Marconi, Vincent C, Ramanan, Athimalaipet V, de Bono, Stephanie, Kartman, Cynthia E, Krishnan, Venkatesh, Liao, Ran, Piruzeli, Maria Lucia B, Goldman, Jason D, Alatorre-Alexander, Jorge, de Cassia Pellegrini, Rita, Estrada, Vicente, Som, Mousumi, Cardoso, Anabela, Chakladar, Sujatro, Crowe, Brenda, Reis, Paulo, Zhang, Xin, Adams, David H, Ely, E Wesley, Ahn, Mi-Young, Akasbi, Miriam, Altclas, Javier David, Ariel, Federico, Ariza, Horacio Alberto, Atkar, Chandrasekhar, Bertetti, Anselmo, Bhattacharya, Meenakshi, Briones, Maria Luisa, Budhraja, Akshay ... Zirpe, Kapil (2021). Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. The Lancet Respiratory Medicine, 9 (12), 1407-1418. doi: 10.1016/S2213-2600(21)00331-3

Olender, Susan A., Perez, Katherine K., Go, Alan S, Balani, Bindu, Price-Haywood, Eboni G., Shah, Nirav S., Wang, Su, Walunas, Theresa L., Swaminathan, Shobha, Slim, Jihad, Chin, BumSik, De Wit, Stéphane, Ali, Shamim M., Soriano Viladomiu, Alex, Robinson, Philip, Gottlieb, Robert L., Tsang, Tak Yin Owen, Lee, I-Heng, Hu, Hao, Haubrich, Richard H., Chokkalingam, Anand P., Lin, Lanjia, Zhong, Lijie, Bekele, B. Nebiyou, Mera-Giler, Robertino, Phulpin, Chloé, Edgar, Holly, Gallant, Joel, Diaz-Cuervo, Helena ... Bernardino, Jose I. (2021). Remdesivir for severe coronavirus disease 2019 (COVID-19) versus a cohort receiving standard of care. Clinical Infectious Diseases, 73 (11), E4166-E4174. doi: 10.1093/cid/ciaa1041

Curtis, Jeffrey R., Zhou, Xiaofeng, Rubin, David T., Reinisch, Walter, Yazdany, Jinoos, Robinson, Philip C., Chen, Yan, Benda, Birgitta, Madsen, Ann and Geier, Jamie (2021). Characteristics, comorbidities, and outcomes of SARS-CoV-2 infection in patients with autoimmune conditions treated with systemic therapies: a population-based study. Journal of Rheumatology, 49 (3), 320-329. doi: 10.3899/jrheum.210888

Rosas, Ivan O., Diaz, George, Gottlieb, Robert L., Lobo, Suzana M., Robinson, Philip, Hunter, Bradley D., Cavalcante, Adilson W., Overcash, J. Scott, Hanania, Nicola A., Skarbnik, Alan, Garcia-Diaz, Julia, Gordeev, Ivan, Carratalà, Jordi, Gordon, Oliver, Graham, Emily, Lewin-Koh, Nicholas, Tsai, Larry, Tuckwell, Katie, Cao, Huyen, Brainard, Diana and Olsson, Julie K. (2021). Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Medicine, 47 (11), 1258-1270. doi: 10.1007/s00134-021-06507-x

Izadi, Zara, Brenner, Erica J., Mahil, Satveer K., Dand, Nick, Yiu, Zenas Z. N., Yates, Mark, Ungaro, Ryan C., Zhang, Xian, Agrawal, Manasi, Colombel, Jean-Frederic, Gianfrancesco, Milena A., Hyrich, Kimme L., Strangfeld, Anja, Carmona, Loreto, Mateus, Elsa F., Lawson-Tovey, Saskia, Klingberg, Eva, Cuomo, Giovanna, Caprioli, Marta, Cruz-Machado, Ana Rita, Mazeda Pereira, Ana Carolina, Hasseli, Rebecca, Pfeil, Alexander, Lorenz, Hanns-Martin, Hoyer, Bimba Franziska, Trupin, Laura, Rush, Stephanie, Katz, Patricia, Schmajuk, Gabriela ... Kappelman, Michael D. (2021). Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19. JAMA Network Open, 4 (10) e2129639, e2129639. doi: 10.1001/jamanetworkopen.2021.29639

Conway, Richard, Brouwer, Elisabeth, van der Geest, Kornelis S.M., Mackie, Sarah L., Mehta, Puja, Putman, Michael, Robinson, Philip and Sattui, Sebastian (2021). Dr. Conway et al reply. The Journal of Rheumatology, 49 (1), 120.2-121. doi: 10.3899/jrheum.210913

Sparks, Jeffrey A., Wallace, Zachary S. and Robinson, Philip C. (2021). Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease. Current Opinion in Rheumatology, 33 (5), 412-418. doi: 10.1097/BOR.0000000000000812

Truong, Steven L., Chin, Jasmine, Liew, David F. L., Zahir, Syeda Farah, Ryan, Elizabeth G., Rubel, Diana, Radford-Smith, Graham and Robinson, Philip C. (2021). Systematic review and meta-analysis of inflammatory bowel disease adverse events with anti-interleukin 17a agents and tumor necrosis factor inhibitors in rheumatic disease and skin psoriasis. Rheumatology and Therapy, 8 (4), 1603-1616. doi: 10.1007/s40744-021-00360-6

Tam, Hoi Ki Joshua, Nash, Peter and Robinson, Philip C. (2021). The effect of etanercept in nonradiographic axial spondyloarthritis by stratified C‐reactive protein levels. ACR Open Rheumatology, 3 (10) acr2.11312, 699-706. doi: 10.1002/acr2.11312

Sparks, Jeffrey A., Wallace, Zachary S., Seet, Andrea M., Robinson, Philip C., Machado, Pedro M. and Yazdany, Jinoos (2021). Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks et al. Annals of the Rheumatic Diseases, 82 (8), e178-e178. doi: 10.1136/annrheumdis-2021-221157

Sparks, Jeffrey A, Wallace, Zachary S, Seet, Andrea M, Gianfrancesco, Milena A, Izadi, Zara, Hyrich, Kimme L, Strangfeld, Anja, Gossec, Laure, Carmona, Loreto, Mateus, Elsa F, Lawson-Tovey, Saskia, Trupin, Laura, Rush, Stephanie, Katz, Patricia, Schmajuk, Gabriela, Jacobsohn, Lindsay, Wise, Leanna, Gilbert, Emily L, Duarte-Garciá, Ali, Valenzuela-Almada, Maria O, Pons-Estel, Guillermo J, Isnardi, Carolina A, Berbotto, Guillermo A, Hsu, Tiffany Y-T, D'Silva, Kristin M, Patel, Naomi J, Kearsley-Fleet, Lianne, Schäfer, Martin, Ribeiro, Sandra Lúcia Euzébio ... Yazdany, Jinoos (2021). Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Annals of the Rheumatic Diseases, 80 (9), 1137-1146. doi: 10.1136/annrheumdis-2021-220418

Sattui, Sebastian E. and Robinson, Philip C. (2021). The COVID-19 pandemic and rheumatology: impact on providing care in Latin America and around the world. The Journal of Rheumatology, 48 (10), 1501-1503. doi: 10.3899/jrheum.210774

Strangfeld, Anja, Schäfer, Martin, Gianfrancesco, Milena A., Lawson-Tovey, Saskia, Liew, Jean W., Ljung, Lotta, Mateus, Elsa F., Richez, Christophe, Santos, Maria J., Schmajuk, Gabriela, Scirè, Carlo A., Sirotich, Emily, Sparks, Jeffrey A., Sufka, Paul, Thomas, Thierry, Trupin, Laura, Wallace, Zachary S., Al-Adely, Sarah, Bachiller-Corral, Javier, Bhana, Suleman, Cacoub, Patrice, Carmona, Loreto, Costello, Ruth, Costello, Wendy, Gossec, Laure, Grainger, Rebecca, Hachulla, Eric, Hasseli, Rebecca, Hausmann, Jonathan S. ... COVID-19 Global Rheumatology Alliance (2021). Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases, 80 (7) e219498, 930-942. doi: 10.1136/annrheumdis-2020-219498

Whittle, Samuel L., Hazlewood, Glen S., Robinson, Philip, Johnston, Renea V., Leder, Karin, Glennon, Vanessa, Avery, Jodie C., Grobler, Liesl and Buchbinder, Rachelle (2021). COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies. Cochrane Database of Systematic Reviews, 2021 (6) CD014991, 1-16. doi: 10.1002/14651858.CD014991

Goldman, Jason D., Robinson, Philip C., Uldrick, Thomas S. and Ljungman, Per (2021). COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. Journal for ImmunoTherapy of Cancer, 9 (6) e002630, e002630. doi: 10.1136/jitc-2021-002630

Conway, Richard, Nikiphorou, Elena, Demetriou, Christiana A, Low, Candice, Leamy, Kelly, Ryan, John G, Kavanagh, Ronan, Fraser, Alexander D, Carey, John J, O’Connell, Paul, Flood, Rachael M, Mullan, Ronan H, Kane, David J, Robinson, Philip C, Liew, Jean W, Grainger, Rebecca, McCarthy, Geraldine M and for the COVID-19 Global Rheumatology Alliance (2021). Predictors of hospitalization in patients with rheumatic disease and COVID-19 in Ireland: data from the COVID-19 global rheumatology alliance registry. Rheumatology Advances in Practice, 5 (2) rkab031, 1-7. doi: 10.1093/rap/rkab031

Tam, Lai‐Shan, Tanaka, Yoshiya, Handa, Rohini, Li, Zhanguo, Lorenzo, Jose Paulo, Louthrenoo, Worawit, Hill, Catherine, Pile, Kevin, Robinson, Philip C., Dans, Leonila F., Hsu, Li Yang, Lee, Sang‐Min, Cho, Jiacai, Hasan, A. T. M. Tanveer, Salim, Babur, Samreen, Saba, Shaharir, Syahrul Sazliyana, Wong, Priscilla, Chau, Jeffrey, Danda, Debashish and Haq, Syed Atiqul (2021). Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID‐19 pandemic. International Journal of Rheumatic Diseases, 24 (6) 1756-185X.14124, 733-745. doi: 10.1111/1756-185x.14124

Rischin, Adam, Liew, David, Black, Rachel, Fletcher, Ashley, Buchbinder, Rachelle, Lassere, Marissa, March, Lyn, Robinson, Philip C., Hill, Catherine and The ARAD Steering Committee† (2021). Healthcare access and attitudes towards telehealth during the early phase of the COVID ‐19 pandemic among an Australian cohort with inflammatory arthritis. Internal Medicine Journal, 51 (5), 788-792. doi: 10.1111/imj.15309

Dalbeth, Nicola and Robinson, Philip C (2021). Patients with gout: an under-recognised group at high risk of COVID-19. The Lancet Rheumatology, 3 (5), e317-e318. doi: 10.1016/S2665-9913(21)00073-4

Liew, David F. L., Dau, Jonathan and Robinson, Philip C. (2021). Value-based healthcare in rheumatology: axial spondyloarthritis and beyond. Current Rheumatology Reports, 23 (6) 36, 36. doi: 10.1007/s11926-021-01003-z

Topless, Ruth K., Phipps‐Green, Amanda, Leask, Megan, Dalbeth, Nicola, Stamp, Lisa K., Robinson, Philip C. and Merriman, Tony R. (2021). Gout, rheumatoid arthritis, and the risk of death related to Coronavirus disease 2019: an analysis of the UK Biobank. ACR Open Rheumatology, 3 (5), 333-340. doi: 10.1002/acr2.11252

Robinson, Philip C., Yazdany, Jinoos and Machado, Pedro M. (2021). Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance. Current Opinion in Rheumatology, 33 (2), 111-116. doi: 10.1097/BOR.0000000000000783

Robinson, Philip C. and Morand, Eric (2021). Divergent effects of acute versus chronic glucocorticoids in COVID-19. The Lancet: Rheumatology, 3 (3), e168-e170. doi: 10.1016/S2665-9913(21)00005-9

Grainger, Rebecca, Machado, Pedro M. and Robinson, Philip C. (2021). Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: epidemiology and outcomes. Best Practice and Research: Clinical Rheumatology, 35 (1) 101657, 101657. doi: 10.1016/j.berh.2020.101657

Machado, Pedro M., Schäfer, Martin, Strangfeld, Anja, Gossec, Laure, Gianfrancesco, Milena, Lawson-Tovey, Saskia, Mateus, Elsa F., Carmona, Loreto, Hyrich, Kimme L., Robinson, Philip C. and Yazdany, Jinoos (2021). Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers. Annals of the Rheumatic Diseases, 82 (5) e116, annrheumdis-2021. doi: 10.1136/annrheumdis-2021-220058

Robinson, Philip C. and Kim, Alfred H. J. (2021). Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease. Best Practice and Research Clinical Rheumatology, 35 (1) 101664, 101664. doi: 10.1016/j.berh.2021.101664

Pathmanathan, K., Robinson, Philip C., Hill, C. L. and Keen, H. I. (2021). The prevalence of gout and hyperuricaemia in Australia: an updated systematic review. Seminars in Arthritis and Rheumatism, 51 (1), 121-128. doi: 10.1016/j.semarthrit.2020.12.001

McEwan, Timothy and Robinson, Philip C. (2021). A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections. Seminars in Arthritis and Rheumatism, 51 (1), 101-112. doi: 10.1016/j.semarthrit.2020.11.007

Gianfrancesco, Milena A. and Robinson, Philip C. (2021). Changing COVID-19 outcomes in patients with rheumatic disease - are we really getting better at this?. The Lancet Rheumatology, 3 (2), e88-e90. doi: 10.1016/S2665-9913(21)00008-4

Takei, Riku, Cadzow, Murray, Markie, David, Bixley, Matt, Phipps-Green, Amanda, Major, Tanya J., Li, Changgui, Choi, Hyon K., Li, Zhiqiang, Hu, Hua, Guo, Hui, He, Meian, Shi, Yongyong, Stamp, Lisa K., Dalbeth, Nicola, Merriman, Tony R., Wei, Wen-Hua, Abhishek, A., Andres, M., Crisan, T., Dalbeth, N., Doherty, M., Jacobsson, L., Janssen, M., Jansen, T. L., Joosten, L. A., Kapetanovic, M., Lioté, F., Matsuo, H. ... Uhlig, T. (2021). Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects. Journal of Human Genetics, 66 (2), 161-169. doi: 10.1038/s10038-020-0821-z

Mackie, Sarah L., Brouwer, Elisabeth, Conway, Richard, van der Geest, Kornelis S. M., Mehta, Puja, Mollan, Susan P., Neill, Lorna, Putman, Michael, Robinson, Philip C. and Sattui, Sebastian E. (2021). Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective. The Lancet. Rheumatology, 3 (1), e71-e82. doi: 10.1016/S2665-9913(20)30386-6

Robinson, Philip C., van der Linden, Sjef, Khan, Muhammad A. and Taylor, William J. (2020). Axial spondyloarthritis: concept, construct, classification and implications for therapy. Nature Reviews Rheumatology, 17 (2), 109-118. doi: 10.1038/s41584-020-00552-4

Robinson, Philip C., Liew, David F. L., Liew, Jean W., Monaco, Claudia, Richards, Duncan, Shivakumar, Senthuran, Tanner, Helen L. and Feldmann, Marc (2020). The potential for repurposing anti-TNF as a therapy for the treatment of COVID-19. Med, 1 (1), 90-102. doi: 10.1016/j.medj.2020.11.005

Amigues, Isabelle, Pearlman, Alexander H, Patel, Aarat, Reid, Pankti, Robinson, Philip C., Sinha, Rashmi, Kim, Alfred Hj, Youngstein, Taryn, Jayatilleke, Arundathi and Konig, Maximilian (2020). Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation. Expert Review of Clinical Immunology, 16 (12), 1185-1204. doi: 10.1080/1744666x.2021.1847084

Robinson, Philip C., Richards, Duncan, Tanner, Helen L. and Feldmann, Marc (2020). Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment. The Lancet Rheumatology, 2 (11), e653-e655. doi: 10.1016/S2665-9913(20)30309-X

Mehta, Puja, Sattui, Sebastian E., van der Geest, Kornelis S. M., Brouwer, Elisabeth, Conway, Richard, Putman, Michael S., Robinson, Philip C. and Mackie, Sarah L. (2020). Giant cell arteritis and COVID-19: similarities and discriminators. A systematic literature review. The Journal of Rheumatology, 48 (7), jrheum.200766-1059. doi: 10.3899/jrheum.200766

Hyrich, Kimme L, Gianfrancesco, Milena, Machado, Pedro M, Yazdany, Jinoos and Robinson, Philip C (2020). Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: ‘Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases’ by Giollo et al. Annals of the Rheumatic Diseases, 81 (11) annrheumdis-2020-218910, annrheumdis-2020. doi: 10.1136/annrheumdis-2020-218910

Gianfrancesco, Milena, Yazdany, Jinoos and Robinson, Philip C. (2020). Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases. Current Opinion in Rheumatology, 32 (5), 434-440. doi: 10.1097/BOR.0000000000000725

Liew, Jean W., Bhana, Suleman, Costello, Wendy, Hausmann, Jonathan S., Machado, Pedro M., Robinson, Philip C., Sirotich, Emily, Sufka, Paul, Wallace, Zachary S., Yazdany, Jinoos and Grainger, Rebecca (2020). The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice. Rheumatology, 60 (1), 353-358. doi: 10.1093/rheumatology/keaa483

Gianfrancesco, Milena, Hyrich, Kimme L, Yazdany, Jinoos, Machado, Pedro M and Robinson, Philip C (2020). COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: ‘Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials – a real-world district general hospital experience’ by Khan et al, ‘Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry’ by Gianfrancesco M et al’ by Andreica et al and ‘COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs’ by Ansarin et al. Annals of the Rheumatic Diseases, 81 (10) 218713, annrheumdis-2020. doi: 10.1136/annrheumdis-2020-218713

Sattui, Sebastian E., Liew, Jean W., Graef, Elizabeth R., Coler-Reilly, Ariella, Berenbaum, Francis, Duarte-García, Alí, Harrison, Carly, Konig, Maximilian F., Korsten, Peter, Putman, Michael S., Robinson, Philip C., Sirotich, Emily, Ugarte-Gil, Manuel F., Webb, Kate, Young, Kristen J., Kim, Alfred H.J. and Sparks, Jeffrey A. (2020). Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Review of Clinical Immunology, 16 (7) 1744666X.2020.1792778, 1-8. doi: 10.1080/1744666X.2020.1792778

Winthrop, Kevin L., Brunton, Amanda E., Beekmann, Susan, Polgreen, Philip, Baddley, John, Saag, Kenneth G., Calabrese, Cassandra, Calabrese, Leonard, Robinson, Philip C., Wallace, Zachary S. and Curtis, Jeffrey R. (2020). SARS CoV-2 infection among patients using immunomodulatory therapies. Annals of the Rheumatic Diseases, 80 (2), annrheumdis-2020. doi: 10.1136/annrheumdis-2020-218580

Hausmann, Jonathan S., Sufka, Paul, Bhana, Suleman, Liew, Jean W., Machado, Pedro M., Wallace, Zachary S., Costello, Wendy, Robinson, Philip C., Yazdany, Jinoos, Grainger, Rebecca and Sirotich, Emily (2020). Conducting research in a pandemic: the power of social media. European Journal of Rheumatology, 7 (S2), S85-S88. doi: 10.5152/eurjrheum.2020.2066

Robinson, Philip C. (2020). Gout models of care: the next step is to facilitate implementation. International Journal of Rheumatic Diseases, 23 (9), 1115-1116. doi: 10.1111/1756-185x.13900

Scheetz, Marc H., Konig, Maximilian F., Robinson, Philip C., Sparks, Jeffrey A. and Kim, Alfred H.J. (2020). A pharmacokinetics‐informed approach to navigating hydroxychloroquine shortages in patients with rheumatic disease during the COVID‐19 pandemic. ACR Open Rheumatology, 2 (8) acr2.11164, 491-495. doi: 10.1002/acr2.11164

Gianfrancesco, Milena, Hyrich, Kimme L., Al-Adely, Sarah, Carmona, Loreto, Danila, Maria I., Gossec, Laure, Izadi, Zara, Jacobsohn, Lindsay, Katz, Patricia, Lawson-Tovey, Saskia, Mateus, Elsa F., Rush, Stephanie, Schmajuk, Gabriela, Simard, Julia, Strangfeld, Anja, Trupin, Laura, Wysham, Katherine D., Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Hausmann, Jonathan S., Liew, Jean W., Sirotich, Emily, Sufka, Paul, Wallace, Zachary S., Yazdany, Jinoos, Machado, Pedro M. and Robinson, Philip C. (2020). Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases, 79 (7), 859-866. doi: 10.1136/annrheumdis-2020-217871

Gianfrancesco, Milena, Hyrich, Kimme L, Yazdany, Jinoos, Machado, Pedro M and Robinson, Philip C (2020). Response to: ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ by Györfi et al. Annals of the Rheumatic Diseases, 80 (6) annrheumdis-2020-218328, annrheumdis-2020. doi: 10.1136/annrheumdis-2020-218328

Robinson, Philip C., Dalbeth, Nicola and Donovan, Peter (2020). Colchicine Prophylaxis of Gout Flares When Commencing Allopurinol is Very Cost Effective. Arthritis Care & Research, 73 (10) acr.24357, 1537-1543. doi: 10.1002/acr.24357

Putman, Michael S., Sufka, Paul, Whittle, Samuel and Robinson, Philip C. (2020). European consensus statements for interstitial lung disease in systemic sclerosis. The Lancet Rheumatology, 2 (6), e317-e318. doi: 10.1016/S2665-9913(20)30085-0

Huang, Xiu-Feng, Li, Zhixiu, De Guzman, Erika, Robinson, Philip, Gensler, Lianne, Ward, Michael M., Rahbar, Mohammad Hossein, Lee, MinJae, Weisman, Michael H., Macfarlane, Gary J., Jones, Gareth T., Klingberg, Eva, Forsblad-d'Elia, Helena, McCluskey, Peter, Wakefield, Denis, Coombes, Jeff S., Singh, Maria A. Fiatarone, Mavros, Yorgi, Vlahovich, Nicole, Hughes, David C., Marzo-Ortega, Helena, Van der Horste-Bruinsma, Irene, O'Shea, Finbar, Martin, Tammy M., Rosenbaum, James, Breban, Maxime, Jin, Zi-Bing, Leo, Paul, Reveille, John D. ... Brown, Matthew A. (2020). Genomewide association study of acute anterior uveitis identifies new susceptibility loci. Investigative Ophthalmology and Visual Science, 61 (6) 3, 1-12. doi: 10.1167/iovs.61.6.3

Konig, Maximilian F, Gianfrancesco, Milena, Yazdany, Jinoos and Robinson, Philip C (2020). Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: ‘Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Carbillon et al. Annals of the Rheumatic Diseases, 80 (4) e55, annrheumdis-2020. doi: 10.1136/annrheumdis-2020-217990

Konig, Maximilian F., Kim, Alfred H. J., Scheetz, Marc H., Graef, Elizabeth R., Liew, Jean W., Simard, Julia, Machado, Pedro M., Gianfrancesco, Milena, Yazdany, Jinoos, Langguth, Daman and Robinson, Philip C. (2020). Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Annals of the Rheumatic Diseases, 79 (10), 1-2. doi: 10.1136/annrheumdis-2020-217690

Wallace, Zachary S., Bhana, Suleman, Hausmann, Jonathan S., Robinson, Philip C., Sufka, Paul, Sirotich, Emily, Yazdany, Jinoos and Grainger, Rebecca (2020). The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Rheumatology, 59 (6), 1204-1206. doi: 10.1093/rheumatology/keaa191

Robinson, Philip C. (2020). Adherence to allopurinol in patients with gout: further insights generate further questions. The Lancet Rheumatology, 2 (5), e249-e250. doi: 10.1016/S2665-9913(20)30060-6

Robinson, Philip C. and Yazdany, Jinoos (2020). The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic. Nature Reviews Rheumatology, 16 (6), 293-294. doi: 10.1038/s41584-020-0418-0

Robinson, Philip C. and Conrad, Diana (2020). Biologic therapy for uveitis: addressing access issues is paramount. Internal Medicine Journal, 50 (4), 508-509. doi: 10.1111/imj.14787

Pietsch, David E. W., Kubler, Paul and Robinson, Philip C. (2020). The effect of reducing systemic inflammation on serum urate. Rheumatology, 59 (10), 3108-3109. doi: 10.1093/rheumatology/keaa085

Day, Richard Osborne, Coleshill, Mathew James, Stocker, Sophie Lena, Nguyen, Amy Danh, Robinson, Philip and Aung, Eindra (2020). Predictors of success in gout treatment. The Journal of Rheumatology, 47 (3), 313-315. doi: 10.3899/jrheum.191150

Bavanendrakumar, Mathuja and Robinson, Philip C. (2020). Author reply. Internal Medicine Journal, 50 (3), 387-387. doi: 10.1111/imj.14696

Stewart, Sarah, Yang, Kevin Chih Kai, Atkins, Kate, Dalbeth, Nicola and Robinson, Philip C. (2020). Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials. Arthritis Research and Therapy, 22 (1) 28, 1-15. doi: 10.1186/s13075-020-2120-7

Robinson, Philip C. (2020). Axial spondyloarthritis: What is it and how is it diagnosed and managed?. Medicine Today, 21 (2), 45-47.

Keen, Helen I., Robinson, Philip C., Dalbeth, Nicola and Hill, Catherine (2020). Time to recognise gout as a chronic disease. Medical Journal of Australia, 212 (6) mja2.50512, 285-285.e1. doi: 10.5694/mja2.50512

Gianfrancesco, Milena A., Hyrich, Kimme L., Gossec, Laure, Strangfeld, Anja, Carmona, Loreto, Mateus, Elsa F., Sufka, Paul, Grainger, Rebecca, Wallace, Zachary, Bhana, Suleman, Sirotich, Emily, Liew, Jean, Hausmann, Jonathan S., Costello, Wendy, Robinson, Philip, Machado, Pedro M., Yazdany, Jinoos and and theCOVID-19 Global Rheumatology Alliance Steering Committee (2020). Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. The Lancet Rheumatology, 2 (5), e250-e253. doi: 10.1016/S2665-9913(20)30095-3

Robinson, Philip C. and Bursle, Evan C. (2020). Management of autoimmune disease during the COVID-19 pandemic. Australian Prescriber, 43 (5), 146-147. doi: 10.18773/austprescr.2020.058

Graef, Elizabeth R., Liew, Jean W., Putman, Michael S., Simard, Julia F., Sirotich, Emily, Berenbaum, Francis, Duarte-García, Alí, Grainger, Rebecca, Harrison, Carly, Konig, Maximilian F., Korsten, Peter, Proulx, Laurie, Richards, Dawn P., Robinson, Philip C., Sattui, Sebastian E., Ugarte-Gil, Manuel Francisco, Young, Kristen J., Kim, Alfred Hj, Sparks, Jeffrey A. and On behalf of COVID-19 Global Rheumatology Alliance (2020). Festina lente: Hydroxychloroquine, covid-19 and the role of the rheumatologist. Annals of the Rheumatic Diseases, 79 (6) 217480, 734-736. doi: 10.1136/annrheumdis-2020-217480

Bursill, David, Taylor, William J., Terkeltaub, Robert, Abhishek, Abhishek, So, Alexander K., Vargas-Santos, Ana Beatriz, Gaffo, Angelo Lino, Rosenthal, Ann, Tausche, Anne-Kathrin, Reginato, Anthony, Manger, Bernhard, Sciré, Carlo, Pineda, Carlos, Van Durme, Caroline, Lin, Ching-Tsai, Yin, Congcong, Albert, Daniel Arthur, Biernat-Kaluza, Edyta, Roddy, Edward, Pascual, Eliseo, Becce, Fabio, Perez-Ruiz, Fernando, Sivera, Francisca, Lioté, Frédéric, Schett, Georg, Nuki, George, Filippou, Georgios, McCarthy, Geraldine, Da Rocha Castelar Pinheiro, Geraldo ... Dalbeth, Nicola (2019). Gout, hyperuricaemia and crystal-associated disease network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Annals of the Rheumatic Diseases, 78 (11), 1592-1600. doi: 10.1136/annrheumdis-2019-215933

Bavan, Mathuja and Robinson, Philip C. (2019). Management of patients with gout and achievement of target serum urate levels at a tertiary rheumatology service in Australia. Internal Medicine Journal, 50 (3) imj.14445, 337-341. doi: 10.1111/imj.14445

Robinson, Philip C., Sengupta, Raj and Siebert, Stefan (2019). Non-radiographic axial spondyloarthritis (nr-axSpA): advances in classification, imaging and therapy. Rheumatology and Therapy, 6 (2), 165-177. doi: 10.1007/s40744-019-0146-6

Robinson, Philip C. (2018). Gout – An update of aetiology, genetics, co-morbidities and management. Maturitas, 118, 67-73. doi: 10.1016/j.maturitas.2018.10.012

Brown, Matthew A., Bird, Paul A., Robinson, Philip C., Mease, Philip J., van den Bosch, Filip, Surian, Christine, Jones, Heather, Szumski, Annette, Marshall, Lisa, Wiid, Zirke and Dougados, Maxime (2018). Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study. Annals of the Rheumatic Diseases, 77 (7), 1090-1093. doi: 10.1136/annrheumdis-2017-211313

Roberts, Rebecca L., Wallace, Mary C., Harrison, Andrew A., White, Douglas, Dalbeth, Nicola, Stamp, Lisa K., Ching, Daniel, Highton, John, Merriman, Tony R., Robinson, Philip C., Brown, Matthew A. and Stebbings, Simon M. (2018). Association of Crohn's disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin. PeerJ, 6 (6) e5088, e5088. doi: 10.7717/peerj.5088

Bursill, David, Taylor, William J., Terkeltaub, Robert, Kuwabara, Masanari, Merriman, Tony R., Grainger, Rebecca, Pineda, Carlos, Louthrenoo, Worawit, Edwards, N. Lawrence, Andrés, Mariano, Vargas-Santos, Ana Beatriz, Roddy, Edward, Pascart, Tristan, Lin, Ching-Tsai, Perez-Ruiz, Fernando, Tedeschi, Sara K., Kim, Seoyoung C., Harrold, Leslie R., McCarthy, Geraldine, Kumar, Nitin, Chapman, Peter T., Tausche, Anne-Kathrin, Vazquez-Mellado, Janitzia, Gutierrez, Marwin, Pinheiro, Geraldo da Rocha Castelar, Richette, Pascal, Pascual, Eliseo, Fisher, Mark C., Burgos-Vargas, Ruben ... Dalbeth, Nicola (2018). Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout. Arthritis Care & Research, 71 (3), 427-434. doi: 10.1002/acr.23607

Robinson, Philip C., Dalbeth, Nicola and Donovan, Peter (2018). The cost-effectiveness of biannual serum urate (SU) monitoring after reaching target in gout: A health economic analysis comparing SU monitoring. Journal of Rheumatology, 45 (5), 697-704. doi: 10.3899/jrheum.170199

Bradbury, Linda A., Hollis, Kelly A., Gautier, Benoît, Shankaranarayana, Sateesh, Robinson, Philip C., Saad, Nivene, Lê Cao, Kim-Anh and Brown, Matthew A (2018). Diffusion-weighted imaging is a sensitive and specific magnetic resonance sequence in the diagnosis of ankylosing spondylitis. Journal of Rheumatology, 45 (6), 771-778. doi: 10.3899/jrheum.170312

Morrisroe, Kathleen, Nakayama, Ayano, Soon, Jason, Arnold, Mark, Barnsley, Les, Barrett, Claire, Brooks, Peter M., Hall, Stephen, Hanrahan, Patrick, Hissaria, Pravin, Jones, Graeme, Katikireddi, Veera Srividya, Keen, Helen, Laurent, Rodger, Nikpour, Mandana, Poulsen, Katherine, Robinson, Philip, Soden, Muriel, Wood, Nigel, Cook, Nicola, Hill, Catherine and Buchbinder, Rachelle (2018). EVOLVE: The Australian Rheumatology Association's 'top five' list of investigations and interventions doctors and patients should question. Internal Medicine Journal, 48 (2), 135-143. doi: 10.1111/imj.13654

Robinson, Philip C. and Dalbeth, Nicola (2018). Febuxostat for the treatment of hyperuricaemia in gout. Expert Opinion On Pharmacotherapy, 19 (11), 1289-1299. doi: 10.1080/14656566.2018.1498842

Robinson, Philip C and Dalbeth, Nicola (2017). Lesinurad for the treatment of hyperuricaemia in people with gout. Expert opinion on pharmacotherapy, 18 (17), 1875-1881. doi: 10.1080/14656566.2017.1401609

Robinson, Philip C., Kempe, Sarina, Tebbutt, Ian and Roberts, Lynden (2017). Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site. International Journal of Rheumatic Diseases, 20 (6), 779-784. doi: 10.1111/1756-185X.12941

Thomas, G., Willner, D., Robinson, P., Cortes, A., Duan, R., Rudwaleit, M., Akkoc, N., Braun, J., Chou, C., Maksymowych, W., Ozgocmen, S., Roussou, E., Sieper, J., Valle-Onate, R., van der Heijde, D., Wei, J., Leo, P. and Brown, M. (2017). Genetic diagnostic profiling in axial spondyloarthritis: a real-world study. Clinical and Experimental Rheumatology, 35 (2), 229-233.

Truong, Steven L., Saad, Nivene F., Robinson, Philip C., Cowderoy, Greg, Lim, Irwin, Schachna, Lionel, Stebbings, Simon, Stuckey, Stephen, Taylor, Andrew L., Whittle, Samuel L., Zochling, Jane, Bird, Paul and Brown, Matthew A. (2017). Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand. Journal of Medical Imaging and Radiation Oncology, 61 (1), 58-69. doi: 10.1111/1754-9485.12573

Robinson, Philip C. and Stamp, Lisa K. (2016). Management of gout - reply. Australian Family Physician, 45 (9), 618-619.

Robinson, Helen, Robinson, Philip, D'Emden, Michael and Mahomed, Kassam (2016). Management of thyroid disease in pregnancy – room for improvement in the first trimester. Obstetric Medicine, 9 (3), 126-129. doi: 10.1177/1753495X16629773

Robinson, Philip C., Choi, Hyon K., Do, Ron and Merriman, Tony R. (2016). Insight into rheumatological cause and effect through the use of Mendelian randomization. Nature Reviews Rheumatology, 12 (8), 486-493. doi: 10.1038/nrrheum.2016.102

Robinson, Philip C., Leo, Paul J, Pointon, Jennifer J., Harris, Jessica, Cremin, Katie, Bradbury, Linda A., Stebbings, Simon, Harrison, Andrew A., Australian Osteoporosis Genetics Consortium, Wellcome Trust Case Control Consortium, Management Committee, Data and Analysis Group, DNA, Genotyping, Data QC and Informatics Group, Publications Committee, Duncan, Emma L., Evans, David M., Wordsworth, Paul B. and Brown, Matthew A. (2016). Exome-wide study of ankylosing spondylitis demonstrates additional shared genetic background with inflammatory bowel disease. NPJ Genomic Medicine, 1 (1) 16008, 16008-6. doi: 10.1038/npjgenmed.2016.8

Robinson, Philip C. and Stamp, Lisa K. (2016). The management of gout: much has changed. Australian Family Physician, 45 (5), 299-302.

Robinson, P. C., Leo, P. J., Pointon, J. J., Harris, J., Cremin, K., Bradbury, L. A., Wellcome Trust Case Control Consortium, Australasian Osteoporosis Genetics Consortium (AOGC), Stebbings, S., Harrison, A. A., Evans, D. M., Duncan, E. L., Wordsworth, B. P. and Brown, M. A. (2016). The genetic associations of acute anterior uveitis and their overlap with the genetics of ankylosing spondylitis. Genes and Immunity, 17 (1), 46-51. doi: 10.1038/gene.2015.49

van der Linden, Sjef, Akkoc, Nurullah, Brown, Matthew A., Robinson, Philip C. and Khan, Muhammad A. (2015). The ASAS criteria for axial spondyloarthritis: strengths, weaknesses, and proposals for a way forward. Current Rheumatology Reports, 17 (9) 62, 62.1-62.12. doi: 10.1007/s11926-015-0535-y

Robinson, Philip C., Taylor, William J. and Dalbeth, Nicola (2015). An observational study of gout prevalence and quality of care in a national Australian general practice population. Journal of Rheumatology, 42 (9), 1702-1707. doi: 10.3899/jrheum.150310

van de Bunt, Martijn, Cortes, Adrian, Brown, Matthew A., Morris, Andrew P., McCarthy, Mark I., IGAS Consortium, Hadler, Johanna, Robinson, Philip C., Leo, Paul, Cremin, Katie, Pryce, Karena, Harris, Jessica, Bradbury, Linda A., Kenna, Tony J. and Yang, Jian (2015). Evaluating the performance of fine-mapping strategies at common variant GWAS Loci. PL o S Genetics, 11 (9) e1005535, 1-14. doi: 10.1371/journal.pgen.1005535

Robinson, Philip C., Costello, Mary-Ellen, Leo, Paul, Bradbury, Linda A., Hollis, Kelly, Cortes, Adrian, Lee, Seunghun, Joo, Kyung Bin, Shim, Seung-Cheol, Weisman, Michael, Ward, Michael, Zhou, Xiaodong, Garchon, Henri-Jean, Chiocchia, Gilles, Nossent, Johannes, Lie, Benedicte A., Forre, Oystein, Tuomilehto, Jaakko, Laiho, Kari, Jiang, Lei, Liu, Yu, Wu, Xin, Elewaut, Dirk, Burgos-Vargas, Ruben, Gensler, Lianne S., Stebbings, Simon, Haroon, Nigil, Mulero, Juan, Luis Fernandez-Sueiro, Jose ... Brown, Matthew A. (2015). ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients. Annals of the Rheumatic Diseases, 74 (8), 1627-1629. doi: 10.1136/annrheumdis-2015-207416

Robinson, Philip C. and Merriman, Tony R. (2015). Correspondence: Does midlife obesity really lower dementia risk?. Lancet Diabetes & Endocrinology, 3 (7), 501-501. doi: 10.1016/s2213-8587(15)00218-1

Robinson, Philip C., Lau, Eugene, Keith, Patricia, Lau, Max C., Thomas, Gethin P., Bradbury, Linda A., Brown, Matthew A. and Kenna, Tony J. (2015). ERAP2 functional knockout in humans does not alter surface heavy chains or HLA-B27, inflammatory cytokines or endoplasmic reticulum stress markers. Annals of the Rheumatic Diseases, 74 (11), 2092-2095. doi: 10.1136/annrheumdis-2015-207467

Kenna, Tony J., Robinson, Philip C. and Haroon, Nigil (2015). Endoplasmic reticulum aminopeptidases in the pathogenesis of ankylosing spondylitis. Rheumatology (United Kingdom), 54 (9), 1549-1556. doi: 10.1093/rheumatology/kev218

Robinson, Philip C. and Brown, Matthew A. (2015). ERAP1 biology and assessment in Ankylosing Spondylitis. Proceedings of the National Academy of Sciences of the United States of America, 112 (15), E1816-E1816. doi: 10.1073/pnas.1501475112

Robinson, Philip C. and Dalbeth, Nicola (2015). Advances in pharmacotherapy for the treatment of gout. Expert Opinion On Pharmacotherapy, 16 (4), 533-546. doi: 10.1517/14656566.2015.997213

Costello, Mary-Ellen, Ciccia, Francesco, Willner, Dana, Warrington, Nicole, Robinson, Philip C., Gardiner, Brooke, Marshall, Mhairi, Kenna, Tony J., Triolo. Giovanni and Brown, Matthew A. (2015). Brief report: intestinal dysbiosis in ankylosing spondylitis. Arthritis and Rheumatology, 67 (3), 686-691. doi: 10.1002/art.38967

Robinson, P. C. and Benham, H. (2015). Advances in classification, basic mechanisms and clinical science in ankylosing spondylitis and axial spondyloarthritis. Internal Medicine Journal, 45 (2), 127-133. doi: 10.1111/imj.12544

Costello, Mary-Ellen, Robinson, Philip C., Benham, Helen and Brown, Matthew A. (2015). The intestinal microbiome in human disease and how it relates to arthritis and spondyloarthritis. Best Practice and Research: Clinical Rheumatology, 29 (2), 202-212. doi: 10.1016/j.berh.2015.08.001

Benham, Helen, Robinson, Philip C., Baillet, Athan C., Rehaume, Linda M. and Thomas, Ranjeny (2015). Role of genetics in infection-associated arthritis. Best Practice and Research: Clinical Rheumatology, 29 (2), 213-225. doi: 10.1016/j.berh.2015.02.002

Robinson, Philip C., Claushuis, Theodora A. M., Cortes, Adrian, Martin, Tammy M., Evans, David M., Leo, Paul, Mukhopadhyay, Pamela, Bradbury, Linda A., Cremin, Katie, Harris, Jessica, Maksymowych, Walter P., Inman, Robert D., Rahman, Proton, Haroon, Nigil, Gensler, Lianne, Powell, Joseph E., Van Der Horst-Bruinsma, Irene E., Hewitt, Alex W., Craig, Jamie E., Lim, Lyndell L., Wakefield, Denis, McCluskey, Peter, Voigt, Valentina, Fleming, Peter, Spondyloarthritis Research Consortium of Canada, Australio-Anglo-American Spondylitis Consortium, International Genetics of Ankylosing Spondylitis Consortium, Wellcome Trust Case Control Study 2, Degli-Esposti, Mariapia ... Brown, Matthew A. (2015). Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis. Arthritis and Rheumatology, 67 (1), 140-151. doi: 10.1002/art.38873

Robinson, Helen L., Robinson, Philip C. and Whitby, Michael (2014). Poor compliance with community-acquired pneumonia antibiotic guidelines in a large Australian private hospital emergency department. Microbial Drug Resistance, 20 (6), 561-567. doi: 10.1089/mdr.2014.0064

Kenna, T. J., Lau, M. C., Keith, P., Ciccia, F., Costello, M. -E., Bradbury, L., Low, P. -L., Agrawal, N., Triolo, G., Alessandro, R., Robinson, P. C., Thomas, G. P. and Brown, M. A. (2014). Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis. Genes and Immunity, 16 (1), 35-42. doi: 10.1038/gene.2014.62

Robinson, Philip C., Bird, Paul, Lim, Irwin, Saad, Nivene, Schachna, Lionel, Taylor, Andrew L., Whittle, Samuel L. and Brown, Matthew A. (2014). Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA). International Journal of Rheumatic Diseases, 17 (5), 548-556. doi: 10.1111/1756-185X.12358

Robinson, Philip C. and Brown, Matthew A. (2014). The window of opportunity: A relevant concept for axial spondyloarthritis. Arthritis Research and Therapy, 16 (3) 109. doi: 10.1186/ar4561

Robinson, Philip C. and Brown, Matthew A. (2014). Genetics of ankylosing spondylitis. Molecular Immunology, 57 (1), 2-11. doi: 10.1016/j.molimm.2013.06.013

Robinson, Philip C. and Horsburgh, Simon (2014). Gout: Joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas, 78 (4), 245-251. doi: 10.1016/j.maturitas.2014.05.001

Robinson, Philip C. and Schumacher, H. Ralph, Jr. (2013). A qualitative and quantitative analysis of the characteristics of gout patient education resources. Clinical Rheumatology, 32 (6), 771-778. doi: 10.1007/s10067-013-2168-8

Robinson, P. C., Taylor, W. J. and Merriman, T. R. (2013). Author reply. Internal Medicine Journal, 43 (4), 466-466. doi: 10.1111/imj.12094

Taylor, William J. and Robinson, Philip C. (2013). Classification criteria: peripheral spondyloarthropathy and psoriatic arthritis. Current Rheumatology Reports, 15 (4) 317. doi: 10.1007/s11926-013-0317-3

Robinson, Philip Cameron, Wordsworth, Bryan Paul, Reveille, John D. and Brown, Matthew A. (2013). Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis. Annals of the Rheumatic Diseases, 72 (2), 162-164. doi: 10.1136/annrheumdis-2012-202073

Robinson, Philip C., Merriman, Tony R., Herbison, Peter and Highton, John (2012). Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999–2009. Rheumatology, 52 (1) kes253, 118-126. doi: 10.1093/rheumatology/kes253

Robinson, P. C., Taylor, W. J. and Merriman, T. R. (2012). Systematic review of the prevalence of gout and hyperuricaemia in Australia. Internal Medicine Journal, 42 (9), 997-1007. doi: 10.1111/j.1445-5994.2012.02794.x

Robinson, Philip C. and Brown, Matthew A. (2012). The genetics of ankylosing spondylitis and axial spondyloarthritis. Rheumatic Disease Clinics of North America, 38 (3), 539-553. doi: 10.1016/j.rdc.2012.08.018

Robinson, Philip C. and Taylor, William J. (2010). Time to Treatment in Rheumatoid Arthritis : Factors Associated With Time to Treatment Initiation and Urgent Triage Assessment of General Practitioner Referrals. JCR: Journal of Clinical Rheumatology, 16 (6), 267-273. doi: 10.1097/rhu.0b013e3181eeb499

Robinson, P C and Steele, R H (2009). Appropriateness of antineutrophil cytoplasmic antibody testing in a tertiary hospital. Journal of Clinical Pathology, 62 (8), 743-745. doi: 10.1136/jcp.2009.064485

Robinson, P., Leo, P., Pointon, J., Harris, J., Cremin, K., Bradbury, L., Stebbings, S., Harrison, A., Duncan, E., Wordsworth, P. and Brown, M. (2015). Exomewide association study of ankylosing spondylitis identifies additional coding region genetic associations with as and strengthens evidence of shared genetic background with inflammatory bowel disease. Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association, 56th Annual Scientific Meeting, Adelaide, South Australia, Australia, 23–26 May 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/imj.12752

Robinson, P., Taylor, W. and Dalbeth, N. (2015). Gout prevalence and quality of care in an Australian general practice population. Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association, 56th Annual Scientific Meeting, Adelaide, South Australia, 23–26 May 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/imj.12752

Horsburgh, S., Highton, J., Stevanovic, V and Robinson, P. (2015). Co-morbidities and mortality in admitted scleroderma patients using a hospital-based population in New Zealand, 1999-2012. Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association, 56th Annual Scientific Meeting, Adelaide, Australia, 23–26 May 2015. HOBOKEN: WILEY-BLACKWELL. doi: 10.1111/imj.12752

Bradbury, Linda A., Hollis, Kelly A., Gautier, Benoit, Shankaranarayana, Sateesh, Robinson, Philip, Saad, Nivene, Le Cao, Kim-Anh and Brown, Matthew A. (2015). Diffusion Weighted Imaging Is a Sensitive and Specific MRI Protocol for the Diagnosis and Assessment of Disease Severity in Ankylosing Spondylitis. unknown, unknown, unknown. HOBOKEN: WILEY-BLACKWELL.

Brown, M., Bird, P., Robinson, P., Mease, P., Van Den Bosch, F., Surian, C., Wiid, Z., Johnson, H., Szumski, A. and Marshall, L. (2015). Baseline Mri/crp as Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis. Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association, Adelaide, SA, Australia, 23-26 May 2015. Richmond, VIC, Australia: Wiley-Blackwell.

Robinson, Philip, Wang, Yang, Lau, Eugene, Keith, Patricia, Kenna, Tony and Brown, Matthew A. (2013). ERAP2 Functional Knockout In Humans Does Not Alter ER Stress Or Evidence Of HLA-B27 Misfolding In Ankylosing Spondylitis.. 77th Annual Meeting of the American College of Rheumatology / 48th Annual Meeting of the Association of Rheumatology Health Professionals, San Diego Ca, 25-30 October 2013. Hoboken, NJ United States: John Wiley and Sons Inc.. doi: 10.1002/art.38216

Robinson, Philip, Claushuis, Dorith, Leo, Paul, Mukhopadhyay, Pamela, Wordsworth, P., Weisman, Michael H., Maksymowych, Walter P., Rahman, Proton, Inman, Robert, Hewitt, Alex, Martin, Tammy M., Rosenbaum, James T., Wakefield, Dennis, Reveille, John D. and Brown, Matthew A. (2013). Genetic Associations In Anterior Uveitis Implicate T-Cell Co-Stimulation and Other Immune Pathways. 77th Annual Meeting of the American College of Rheumatology / 48th Annual Meeting of the Association of Rheumatology Health Professionals, San Diego CA, United States, 25-30 October 2013 Proceedings title Abstract Supplement 2013 Annual Meeting. Hoboken, NJ United States: John Wiley and Sons. doi: 10.1002/art.38216

Bradbury, L., Hollis, K., Chay, J., Robinson, P. and Brown, M. (2013). Ustekinumab in Ankylosing Spondylitis and Ulcerative Colitis. 54th Annual Scientific Meeting of the Australian Rheumatology Association in conjunction with the Rheumatology Health Professionals Association, Perth, WA Australia, 18 -22 May 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/imj.12142

Robinson, Philip (2012). Recent advances in biological therapies in rheumatic diseases. RACP Future Directions in Health Congress 2012, Brisbane, Australia, 6-9 May 2012. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1445-5994.2012.02779.x

Robinson, Philip, Cortes, Adrian, Leo, Paul, Evans, David and Brown, Matthew A. (2012). Ankylosing spondylitis is associated with single nucleotide polymorphisms in loci implicating four aminopeptidases. Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, DC, United States, 9-14 November 2012. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/art.37735

Cortes, Adrian, Robinson, Philip and Brown, Matthew A. (2012). Dense genotyping of candidate genes identifies 16 new susceptibility loci in ankylosing spondylitis. Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, DC, United States, 9-14 November 2012. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/art.37735

Robinson, P. C., Cortes, A., Leo, P., Evans, D. M. and Brown, M. A. (2012). Ankylosing spondylitis is associated with snps in loci implicating four aminopeptidases. 8th International Congress on Spondyloarthritis, Granada, Spain, 9-13 May 2012. Ospedaletto, Italy: Pacini Editore SpA.

Cortes, A., Robinson, P. C., Hadler, J., Leo, P., Evans, D. M. and Brown, M. A. (2012). Dense genotyping of candidate genes identifies 16 new susceptibility loci in ankylosing spondylitis. Eighth International Congress on Spondyloarthropathies, Gent, Belgium, 4-6 October 2012. Ospedaletto, PI, Italy: Pacini Editore.

Bradbury, L., McFarlane, J., Robinson, P. and Brown, M. (2012). Tnfi failures: experience in a specialist ankylosing spondylitis clinic. Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting Conference, Canberra, ACT Australia, 12-15 May 2012. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Saad, N., Bradbury, L., McFarlane, J., Hollis, K., Brown, M. and Robinson, P. (2012). Diffusion-weighted magnetic resonance imaging in the detection of sacroiliitis. Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting Conference, Canberra, ACT Australia, 12-15 May 2012. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Kenna, T. J., Lau, M. C., Costello, M. E., Robinson, P. and Brown, M. A. (2012). Disease-associated erapi variants do not alter endoplasmic reticulum stress in ankylosing spondylitis. 8th International Congress on Spondyloarthritis, Granada, Spain, 9-13 May 2012. Ospedaletto, Italy: Pacini Editore SpA.

Robinson, Philip C. (2014). The genetics of ankylosing spondylitis and anterior uveitis. PhD Thesis, UQ Diamantina Institute, The University of Queensland. doi: 10.14264/uql.2015.24

Associate Professor Philip Robinson

Publications

Book Chapters

Journal Articles

Conference Papers

Thesis